The majority of Directors of Investor Relations at Par Pharmaceuticals believe they're compensated fairly. The vast majority (100%) of Directors of Investor Relations at Par Pharmaceuticals are satisfied with their benefits. See more compensation ratings at Par Pharmaceuticals